Test-retest validity of Parkinson's disease sleep scale 2nd version (PDSS-2)

Journal of Parkinson's Disease

Volumn 4, Issue 4, 2014, Pages 687-691

  Horváth, Krisztina ^a   Aschermann, Zsuzsanna ^a   Ács, Péter ^a   Deli, Gabriella ^a   Janszky, József ^a   Karádi, Kázmér ^a   Komoly, Sámuel ^a   Faludi, Béla ^a   Kovács, Norbert ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

Author keywords

concordance; intraclass correlation coefficient; scale; Sleep

Indexed keywords

LEVODOPA;

ADULT; ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; EQ 5D; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONTGOMERY ASBERG DEPRESSION RATING SCALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PARKINSON DISEASE; PARKINSON DISEASE SLEEP SCALE 2ND VERSION; QUALITY OF LIFE; SCORING SYSTEM; SLEEP QUALITY; TEST RETEST RELIABILITY; TEST RETEST VALIDITY; UNIFIED PARKINSON DISEASE RATING SCALE; VALIDATION PROCESS; VALIDATION STUDY; VALIDITY;

EID: 84914667972     PISSN: 18777171     EISSN: 1877718X     Source Type: Journal    
DOI: 10.3233/JPD-140459     Document Type: Article

References (12)

1. Santos-Garcia D, & de la Fuente-Fernandez R (2013) Impact of non-motor symptoms on health-related and perceived quality of life in Parkinson's disease. J Neurol Sci, 332, 136-140.
2. Trenkwalder C, Kohnen R, Hogl B, Metta V, Sixel-Doring F, Frauscher B, Hulsmann J, Martinez-Martin P, & Chaudhuri KR (2011) Parkinson's disease sleep scale-validation of the revised version PDSS-2. Mov Disord, 26, 644-652.
3. Kovács N, Pál E, Janszky J, Bosnyák E, Á cs P, Aschermann Z, & Faludi B (2013) Parkinson's disease Sleep Scale-2 and Epworth Sleep Scale. J Neurol Sci 333, e139.
4. Swick TJ, Friedman JH, Chaudhuri KR, Surmann E, Boroojerdi B, Moran K, Ghys L, & Trenkwalder C (2014) Associations between severity of motor function and nonmotor symptoms in Parkinson's Disease: A post hoc analysis of the RECOVER study. Eur Neurol, 71, 140-147.
5. Takanashi M, Shimo Y, Hatano T, Oyama G, & Hattori N (2013) Efficacy and safety of a once-daily extended-release formulation of pramipexole switched from an immediaterelease formulation in patients with advanced Parkinson's disease: Results from an open-label study. Drug Res (Stuttg), 63, 639-643.
6. Zibetti M, Rizzone M, Merola A, Angrisano S, Rizzi L, Montanaro E, Cicolin A, & Lopiano L (2013) Sleep improvement with levodopa/carbidopa intestinal gel infusion in Parkinson disease. Acta Neurol Scand, 127, e28-e32.
7. Kovács N, Aschermann Z, Á cs P, Bosnyák E, Deli G, Janszky J, & Komoly S (2014) Levodopa/carbidopa intestinalis gél kezelés hatása az életminoségre [The impact of levodopacarbidopa intestinal gel on health-related quality of life in Parkinson's disease]. Ideggyogy Sz 67, 245-250.
8. Kaszas B, Kovacs N, Balas I, Kallai J, Aschermann Z,Kerekes Z, Komoly S, Nagy F, Janszky J, Lucza T, & Karadi K (2012) Sensitivity and specificity of Addenbrooke's Cognitive Examination, Mattis Dementia Rating Scale, Frontal Assessment Battery and Mini Mental State Examination for diagnosing dementia in Parkinson's disease. Parkinsonism Relat Disord 18, 553-556.
9. Horváth K, Aschermann Z, Á cs P, Bosnyák E, Deli G, Pál E, Késmárki I, Horváth R, Takács K, Komoly S, Bokor M, Rigó E, Lajtos J, Klivényi P, Dibó G, Vécsei L, Takáts A, Tóth A, Imre P, Nagy F, Herceg M, Hidasi E, & Kovács N (2014) Validation of the Hungarian MDS-UPDRS: Why do we need a new Parkinson scale Ideggyogy Sz 67, 129-134.
10. Szende A, &Williams A(2004) Measuring self-reported population health: An international perspective based on EQ-5D, Springmed Publishing Ltd.
11. Lin LI (1989) A concordance correlation coefficient to evaluate reproducibility. Biometrics, 45, 255-268.
12. Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, & Clarke CE (2010) Systematic review of levodopa dose equivalency reporting in Parkinson's disease. Mov Disord, 25, 2649-2653.